Oshrat Levi-Galibov

846 citations
7 papers · 255 indexed · h-index 6
Topics
Cancer Cells and Metastasis (4 papers)Heat shock proteins research (3 papers)Endoplasmic Reticulum Stress and Disease (2 papers)
Partner nations
IsraelUnited StatesItaly

In The Last Decade

Oshrat Levi-Galibov

7 papers receiving 255 citations

Peers

Oshrat Levi-Galibov
Comparison fields: 5 of 53
  • Molecular Biology 135
  • Oncology 122
  • Cancer Research 69
  • Immunology 66
  • Pulmonary and Respiratory Medicine 38
Replace Liqiu Liao with:
Liqiu Liao China
Adi Zipin‐Roitman Israel
Natascha Santacroce Switzerland
Hui‐Lung Sun Taiwan
Terry J. Shackleford United States
Eva Rodríguez-Aznar Spain
Anjali Geethadevi United States
David Kallenberg United Kingdom
María Pérez-Lanzón France
Jane Ho Chun Loong China
Oshrat Levi-Galibov relative to Liqiu Liao China Liqiu Liao's profile →
Citations per field
00.5×1.5×2.5×
Liqiu Liao · 1×
Citations per year

Countries citing papers authored by Oshrat Levi-Galibov

Since Specialization
Citations

This map shows the geographic impact of Oshrat Levi-Galibov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oshrat Levi-Galibov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oshrat Levi-Galibov more than expected).

Fields of papers citing papers by Oshrat Levi-Galibov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oshrat Levi-Galibov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oshrat Levi-Galibov. The network helps show where Oshrat Levi-Galibov may publish in the future.

Co-authorship network of co-authors of Oshrat Levi-Galibov

This figure shows the co-authorship network connecting the top 25 collaborators of Oshrat Levi-Galibov. A scholar is included among the top collaborators of Oshrat Levi-Galibov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oshrat Levi-Galibov. Oshrat Levi-Galibov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 12
2 21
3 71
4 55
5 26
6 67
7 3

About Oshrat Levi-Galibov

Oshrat Levi-Galibov is a scholar working on Immunology and Allergy, Oncology and Cell Biology, having authored 7 papers that have together received 255 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (4 papers), Heat shock proteins research (3 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). The work is most often cited by research in Cancer Research (69 citations), Oncology (122 citations) and Aging (6 citations). Oshrat Levi-Galibov has collaborated with scholars based in Israel, United States and Italy. Frequent co-authors include Ruth Scherz‐Shouval, Yaniv Stein, Shimrit Mayer, Meirav Pevsner‐Fischer, Hagar Lavon, Gil Friedman, Neta Regev‐Rudzki, Tal Goshen‐Lago, Noam Cohen and Irit Ben‐Aharon. Their work appears in journals such as Nature Communications, Cancer Research and eLife.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026